SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-179069
Filing Date
2015-05-08
Accepted
2015-05-08 13:04:54
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d899256d10q.htm 10-Q 236113
2 EX-31.1 d899256dex311.htm EX-31.1 5895
3 EX-31.2 d899256dex312.htm EX-31.2 5867
4 EX-32.1 d899256dex321.htm EX-32.1 3775
5 EX-32.2 d899256dex322.htm EX-32.2 3873
  Complete submission text file 0001193125-15-179069.txt   2562246

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ccxi-20150331.xml EX-101.INS 298975
7 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20150331.xsd EX-101.SCH 26685
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20150331_cal.xml EX-101.CAL 43125
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20150331_def.xml EX-101.DEF 63702
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20150331_lab.xml EX-101.LAB 220168
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20150331_pre.xml EX-101.PRE 152634
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 15845528
SIC: 2834 Pharmaceutical Preparations